# FDA recall D-0576-2023

> **RemedyRepack Inc.** · Class II · drug recall initiated 2023-05-01.

## Product

LORazepam Injection, 2mg / mL  Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045, Repackaged by: RemedyRepack Inc., Indiana PA 15701, Source NDC # 17478-0040-01, Remedy NDC 70518-2268-00

## Reason for recall

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

## Distribution

Product was distrituded to three direct account in PA.

## Key facts

- **Recall number:** D-0576-2023
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-05-01
- **Report date:** 2023-05-24
- **Termination date:** 2023-06-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0576-2023

## Citation

> AI Analytics. FDA recall D-0576-2023. Retrieved 2026-07-19 from https://api.ai-analytics.org/recall/D-0576-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*